Comparison of drug-coated balloon angioplasty versus uncoated balloon angioplasty in treatment of total occlusions with severe femoropopliteal lesions: An additional analysis from the AcoArt I study.

CONCLUSION: The paclitaxel drug-coated balloon shows better primary patency and freedom from target lesion revascularization than POBA at 24 months after treatment of femoropopliteal chronic total occlusions (≥5 cm) lesion. PMID: 32903168 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32903168?dopt=Abstract

Source: Vascular - September 8, 2020 Category: Surgery Authors: Sun G, Liu J, Jia S, Zhang J, Zhuang B, Jia X, Fu W, Wu D, Wang F, Zhao Y, Guo P, Bi W, Wang S, Guo W, AcoArt I Trial Investigators Tags: Vascular Source Type: research

More News: Angioplasty | Baloon Angioplasty | Study | Surgery